Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Whitaker Myers Wealth Managers LTD.

Whitaker Myers Wealth Managers LTD. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 59.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 389 shares of the biotechnology company’s stock after selling 575 shares during the period. Whitaker Myers Wealth Managers LTD.’s holdings in Axon Enterprise were worth $231,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Quent Capital LLC lifted its stake in shares of Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC lifted its stake in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $41,000. Planning Capital Management Corp lifted its stake in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares in the last quarter. Finally, Friedenthal Financial acquired a new position in Axon Enterprise during the 3rd quarter worth about $51,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,545 shares of company stock worth $30,721,337. 5.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on AXON shares. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. JMP Securities increased their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $504.92.

Axon Enterprise Stock Up 1.4 %

Shares of NASDAQ:AXON opened at $593.89 on Friday. The company has a market capitalization of $45.28 billion, a PE ratio of 153.46, a P/E/G ratio of 5.71 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The firm has a 50 day simple moving average of $617.37 and a 200-day simple moving average of $459.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.